Introduction {#S1}
============

Mammalian lung is a complex, stereotypically branched organ, whose development is strictly regulated by multiple signaling pathways. They include fibroblast growth factor (FGF) ([@B23]; [@B35]; [@B45]; [@B11]; [@B5]), WNT ([@B43]; [@B54]), bone morphogenetic protein ([@B50]; [@B26]; [@B43]), Sonic Hedgehog ([@B31]; [@B52]), epidermal growth factor (EGF) ([@B21]), retinoic acid ([@B27]), and HIPPO ([@B49]) pathways. Tight interplay of these pathways is essential also for lung epithelial homeostasis, regeneration, and repair ([@B47]; [@B48]).

FGF signaling plays an essential role in lung development from the very earliest stages. FGF4 is involved in organ-specific domain formation along the anteroposterior axis of the early endoderm ([@B51]; [@B12]). Later, FGF10-FGFR2b signaling is essential for lung bud formation and to control branching morphogenesis of the lung. Deletion of either *Fgf10* or *Fgfr2b* results in complete distal lung agenesis ([@B32]; [@B41]; [@B10]), while *Fgf10* hypomorphic lungs display decreased ramifications ([@B39]). *Fgf10* gain-of-function prevents differentiation of epithelial tip cells toward the bronchial progenitor lineage and disrupts lung morphogenesis ([@B34]; [@B46]). Furthermore, FGF1, FGF2, FGF7, and FGF9 were found in fetal rodent lung, too ([@B18]; [@B4]; [@B37]; [@B8]; [@B20]). FGF7 acts as a proliferative factor for lung epithelium during lung development ([@B23]), and together with FGF2, it induces expression of surfactant proteins ([@B28]). FGF9 is responsible for mesenchymal cell proliferation, and it is also involved in lung epithelium regulation ([@B11]).

The role of FGF signaling in lung development and homeostasis is interwoven with WNT signaling. FGF and WNT signaling regulate proximal/distal patterning and fate of lung progenitor cells ([@B47]). Canonical WNT signaling is required for mesenchymal expression of FGF10 and primary lung bud formation ([@B16]). Furthermore, mesenchymal WNT signaling regulates amplification of *Fgf10* expressing airway smooth muscle cell progenitors in the distal mesenchyme ([@B47]). In adult lung, FGF10 and WNT signaling regulate the activity of basal cells, the lung epithelial stem/progenitor cells (LSPCs) that ensure lung epithelial homeostasis and repair after injury ([@B46]). However, the exact functions of FGF and WNT signaling in LSPCs have not been fully elucidated.

In this study, we investigated the role of FGF and WNT signaling in the regulation of postnatal lung epithelial morphogenesis and homeostasis from LSPCs. To this end, we developed and used several 3D cell culture techniques, including lungosphere and lung organoid assays, and we investigated the ability of various FGF ligands and WNT signaling to support LSPC survival and differentiation to epithelial structures.

Results {#S2}
=======

Lungosphere Assay Demonstrates the Existence of Cells With Capacity for Anchorage-Independent Growth and Self-Renewal {#S2.SS1}
---------------------------------------------------------------------------------------------------------------------

Stem and progenitor cells are defined by their capacities to self-renew (i.e., to replicate and form more of the same cells), as well as to produce more differentiated progeny ([@B15]). On top of that, one of the distinctive characteristics of stem and progenitor cells is their ability to resist anoikis and to survive in non-adherent conditions ([@B36]). These characteristics have been applied in sphere formation assays, such as neurosphere ([@B40]) or mammosphere ([@B42]) formation assays and, to some extent, also in lung cancer sphere formation assays ([@B56]). We applied this approach to isolate LSPCs. Single epithelial cells from mouse lung were seeded in non-adherent plates in a defined serum-free medium with epidermal growth factor (EGF) and FGF2 and cultured for 10--14 days, with the addition of a fresh medium every 3 days ([@B42]; [@B38]). Because FGF2 rapidly loses its biological activity at 37°C, we tested the use of FGF2-wt, as well as FGF2 with increased thermal stability (FGF2-STAB) ([@B13]) and sustained FGFR specificity ([@B22]) for their capacity to support lungosphere formation. With FGF2-wt, the lungosphere formation efficiency (LFE) was 0.088 ± 0.006% ([Supplementary Figures 1A,B](#SM1){ref-type="supplementary-material"}), and the lungospheres were of three different phenotypes: grape-like, cystic with a clearly defined lumen, and compound with regions resembling both the grape-like and the cystic phenotype. With FGF2-STAB, lungospheres were formed with the same phenotypes as with FGF2-wt; however, they formed with significantly higher LFE (0.132 ± 0.015%) ([Figures 1A,B](#F1){ref-type="fig"} and [Supplementary Figure 1B](#SM1){ref-type="supplementary-material"}).

![Lung epithelium contains LSPCs that form lungospheres with the capacity for self-renewal and differentiation. **(A,B)** Lungospheres formed from unsorted lung epithelial cells in non-adherent conditions with EGF and FGF2. **(A)** Representative photographs of primary and secondary lungospheres. Scale bar, 100 μm. **(B)** The efficiency of primary and secondary lungosphere formation with EGF and FGF2. The plots show mean + SD; *n* = 5. **(C,D)** Lungospheres formed from FACS-sorted EpCAM^+^, CD49f^+^, CD24^low^, CD104^+^ cells in non-adherent conditions with EGF and FGF2**(C)** Representative photographs of primary and secondary lungospheres. Scale bar, 100 μm. **(D)** The efficiency of primary and secondary lungosphere formation with EGF and FGF2. The plots show mean + SD; *n* = 3 (*n* = 1 for tertiary lungospheres). The columns left from the dashed vertical line show LFE from cells cultured at thousands of cells per well; the column right from the line shows LFE from cells cultured individually -- a single cell per well. **(E,F)** The efficiency of primary and secondary lungosphere formation of FACS-sorted EpCAM^+^, CD49f^+^, CD24^hi^, CD104^+^ **(E)** and EpCAM^+^, CD49f^+^, CD24^neg^, CD104^neg^ **(F)** cells in non-adherent conditions with EGF and FGF2. The plots show mean + SD; *n* = 1. **(G,H)** Primary lungospheres grown in non-adherent conditions form lung-like structures. **(G)** The photographs of hematoxylin/eosin-stained paraffin sections show alveolar-like structures (arrowheads) and airways-like structures (arrows). **(H)** Immunofluorescence staining of paraffin sections for E-cadherin, keratin 5 (K5), keratin 8 (K8), keratin 14 (K14), Pro-SPB, Pro-SPC, aquaporin 5 (AQP5), CC10, MUC5AC, lysozyme (Lys), and nuclei (DAPI). **(I--K)** Lungospheres embedded in 3D Matrigel and cultured with EGF and FGF2 proliferate and form large organoids with lung-like structure. **(I)** The photographs show morphogenesis of a lungosphere-derived organoid over 32 days. **(J)** Hematoxylin/eosin-stained section of lungosphere-derived organoid. **(K)** Immunofluorescence staining of paraffin sections of lungosphere-derived organoids for keratin 5 (K5), cytokeratin 8 (K8), Pro-SPC, CC10, AQP5, and nuclei (DAPI). **(G--K)** Scale bar, 100 μm.](fcell-08-00574-g001){#F1}

To test the capacity of these spheres to self-renew, we performed a secondary lungosphere assay. Primary lungospheres were disintegrated to single cells and seeded again in non-adherent conditions. After 14 days of cultivation, secondary lungospheres of similar phenotypes as the primary lungospheres were formed at LFE 0.150 ± 0.055% ([Figures 1A,B](#F1){ref-type="fig"}), whereas the LFE in the presence of FGF2-wt was lower (0.100 ± 0.029%) ([Supplementary Figure 1C](#SM1){ref-type="supplementary-material"}).

To investigate what cells of the lung epithelium are capable of lungosphere formation, we sorted the lung epithelial cells by FACS according to markers for adult lung stem cells ([@B29]) and cultured them in non-adherent conditions. The adult lung stem cell-enriched population characterized by EpCAM^+^, CD49f^+^, CD24^low^, CD104^+^ status ([@B29]) formed primary and secondary lungospheres of similar phenotypes as unsorted cells and with LFE 1.475 ± 0.150% for primary and 1.967 ± 0.208% for secondary lungospheres, respectively ([Figures 1C,D](#F1){ref-type="fig"}). In contrast, EpCAM^+^, CD49f^+^, CD24^hi^, CD104^+^ and EpCAM^+^, CD49f^+^, CD24^neg^, CD104^neg^ cells formed only primary lungospheres with LFE 1.4% and 0.2%, respectively, and failed to form secondary lungospheres ([Figures 1E,F](#F1){ref-type="fig"}). These results indicated that the self-renewing lungosphere-forming stem cells are present in the EpCAM^+^, CD49f^+^, CD24^low^, CD104^+^ population.

To test whether the lungospheres were clonal and formed by the division of single stem cells rather than being formed by cell aggregation, we sorted single EpCAM^+^, CD49f^+^, CD24^low^, CD104^+^ cells directly in 96-well plates at only one cell per well in non-adherent conditions. We observed the formation of lungospheres with LFE 1.733 ± 0.153% ([Figure 1D](#F1){ref-type="fig"}), which was similar to the primary LFE when thousands of cells were cultured together in one well, suggesting that the lungospheres were clonal.

Histological analysis of primary lungospheres grown from unsorted cells in non-adherent conditions revealed that lungospheres formed lung-like structures, with both alveolar-like and airways-like morphologies ([Figure 1G](#F1){ref-type="fig"}). Using immunofluorescence analysis of the lungospheres, we detected cells positive for lung epithelial cell markers cytokeratin 8 (K8) and E-cadherin, basal cell markers cytokeratin 5 (K5) and cytokeratin 14 (K14), club cell marker CC10, mucous cell marker MUC5AC, marker of secretory serous cells in the respiratory pathway lysozyme, markers of ATII cells prosurfactant protein B (pro-SPB) and prosurfactant protein C (pro-SPC), and the marker of the ATI cells aquaporin 5 (AQP5) ([Figure 1H](#F1){ref-type="fig"}). Ultrastructural analysis by transmission electron microscopy showed that a lungosphere is composed of a group of cells connected by tight junctions ([Supplementary Figure 2A](#SM1){ref-type="supplementary-material"}). Some of the lungosphere cells have a dense cytoplasm that is rich in mitochondria and lamellar bodies ([Supplementary Figure 2A](#SM1){ref-type="supplementary-material"}).

In summary, our observations suggest that postnatal lung epithelium contains LSPCs with the ability to resist anoikis, to self-renew, and to form clonal spheres containing both stem/progenitor cells and more differentiated cells, and that the LSPCs can be efficiently isolated from the lung using the lungosphere assay without the requirement for FACS.

Lung Epithelial Cells Form Organoids in 3D Matrigel {#S2.SS2}
---------------------------------------------------

Extracellular matrix (ECM) provides regulatory signals for epithelial tissue growth and patterning ([@B9]). Therefore, we embedded lungospheres formed in non-adherent conditions in 3D Matrigel and cultured them for over 30 days to investigate the morphogenesis of lungospheres in a physiologically more relevant setting. We observed the formation of large cystic and/or branched organoids ([Figure 1I](#F1){ref-type="fig"}). These organoids had a complex lung-like structure ([Figure 1J](#F1){ref-type="fig"}). Ultrastructural analysis by transmission electron microscopy revealed different types of cells present in the lungosphere-derived organoids ([Supplementary Figure 2B](#SM1){ref-type="supplementary-material"}). They included ATI cell-like simple squamous cells with central nucleus and a thin cytoplasm, ATII cell-like cuboidal cells with central nucleus and cytoplasm rich in mitochondria and lamellar bodies, and club cell-like columnar cells with basally located nucleus and lamellar bodies within the cytoplasm ([Supplementary Figure 2B](#SM1){ref-type="supplementary-material"}). This cell diversity was further supported by the presence of a variety of epithelial and lung cell markers, including K5, K8, Pro-SPC, CC10, and AQP5 ([Figure 1K](#F1){ref-type="fig"}), as found by immunofluorescence.

Next, we investigated the ability of unsorted lung epithelial cells to form lung organoids directly in Matrigel from single cells. The cells were cultured in 3D Matrigel in the same medium as lungospheres. We observed the formation of organoids with efficiency (organoid forming efficiency, OFE) of 0.110 ± 0.007% ([Figure 2A](#F2){ref-type="fig"}), which was similar to the LFE of unsorted lung epithelial cells. Control experiments with FGF2-wt showed the formation of lung organoids with similar phenotype but at lower OFE (0.067 ± 0.008%) ([Supplementary Figures 3A,B](#SM1){ref-type="supplementary-material"}). The organoids, which had developed in the presence of FGF2-wt, did not show any significant difference in branching efficiency in comparison to organoids developed in the presence of FGF2-STAB ([Supplementary Figure 3C](#SM1){ref-type="supplementary-material"}). However, we observed a significantly higher proportion of K8-positive to K5-positive cells in the FGF2-STAB organoids ([Supplementary Figures 3D,E](#SM1){ref-type="supplementary-material"}).

![FGFs promote formation, proliferation, and branching of lung organoids. **(A--C)** In 3D Matrigel, lung organoids are efficiently formed in response to different FGFs. **(A)** Primary lung organoid forming efficiency (OFE). The plot shows mean + SD; *n* = 3--5. \*\*\*\**P* \< 0.0001 (one-way ANOVA). **(B)** Branching efficiency (%) of lung organoids on day 21 of culture, shown as mean + SD; *n* = 3--4. \**P* \< 0.05 (one-way ANOVA). **(C)** Representative photographs of primary lung organoids formed in 3D Matrigel in response to different FGFs (1 nM). Scale bar, 100 μm. **(D)** Increased concentration of FGFs increases organoid forming efficiency. The plot shows primary lung OFE as mean + SD; *n* = 3--5. \*\*\*\**P* \< 0.0001 (two-way ANOVA). **(E--H)** EGF is not essential for lung organoid formation in the presence of FGFs. **(E)** Representative photographs of primary lung organoids formed in 3D Matrigel in the presence of different FGFs (2 nM) and in the absence of EGF. Scale bar, 100 μm. **(F,G)** The plots show primary **(F)** and secondary **(G)** lung organoid forming efficiency as mean + SD; *n* = 3--4. \*\**P* \< 0.01; \*\*\*\**P* \< 0.0001 (two-way ANOVA). **(H)** Analysis of organoid size. The sizes are relative to organoids formed in a medium with EGF and no FGF. The plots show mean + SD; *n* = 3, *N* = 15--20 organoids/treatment. The gray symbols indicate significance between the culture with and without EGF for the respective FGF. \*\*\*\**P* \< 0.0001 (two-way ANOVA). **(I--K)** Initial treatment with FGF2 for 7 days increases lung organoid formation and branching efficiency in response to FGF7, FGF9, and FGF10. **(I)** Representative photographs of primary lung organoids formed in 3D Matrigel after 7 days of culture with 1 nM FGF2, followed by culture with different FGFs (1 nM). The pictures are from day 20 of culture. Scale bar, 100 μm. **(J,K)** The plots show primary lung OFE **(J)** and branching efficiency of lung organoids **(K)** as mean + SD; *n* = 3. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001 (two-way ANOVA).](fcell-08-00574-g002){#F2}

Different FGF Ligands Contribute Differently to Lung Organoid Formation {#S2.SS3}
-----------------------------------------------------------------------

During lung development, different FGFs are differently required at specific stages of lung specification and morphogenesis ([@B47]). Therefore, we investigated the effect of different FGFs on lung organoid formation. To this end, we cultured unsorted lung epithelial cells in 3D Matrigel with EGF (20 ng/ml) and FGF2, FGF7, FGF9, or FGF10 (all at 1 nM). We found that with the different FGFs tested, the organoids formed with similar efficiencies as with FGF2, except for FGF9 with which the organoids formed with significantly lower efficiency (0.110 ± 0.007%, 0.117 ± 0.006%, 0.053 ± 0.017%, and 0.123 ± 0.017% for FGF2, FGF7, FGF9, and FGF10, respectively) ([Figures 2A,C](#F2){ref-type="fig"}). Analysis of the organoid morphology revealed that FGF7 and FGF10, respectively, supported the formation of more complex, branched structures in a significantly higher proportion of organoids ([Figure 2B](#F2){ref-type="fig"} and [Supplementary Figure 4A](#SM1){ref-type="supplementary-material"}). For all FGFs tested, the increase in their concentration to 2 nM has led to at least twofold increase in numbers of produced organoids ([Figure 2D](#F2){ref-type="fig"}).

Next, we tested the requirement of EGF for lung organoid formation. To this end, we cultured the lung epithelial cells in 3D Matrigel with media containing different FGFs (2 nM) in the presence (20 ng/ml) or absence of EGF. We found that lung organoids formed also in the absence of EGF ([Figure 2E](#F2){ref-type="fig"}). However, removal of EGF from the cell culture media significantly reduced primary lung organoid formation in the case of culture with FGF2 and FGF9, and reduced secondary OFE in the case of FGF9 ([Figures 2F,G](#F2){ref-type="fig"}). No organoids formed in the absence of both EGF and FGF. However, EGF on its own was capable of supporting lung organoid formation at low OFE ([Figures 2F,G](#F2){ref-type="fig"}).

Analysis of the organoid morphology revealed that organoids that formed in the absence of EGF were significantly smaller compared to those formed with EGF ([Figure 2H](#F2){ref-type="fig"}). Also, organoids formed with FGF7 and/or FGF10 were significantly bigger than the organoids formed with FGF2 and/or FGF9 ([Figure 2H](#F2){ref-type="fig"}). Moreover, FGF7 and FGF10 induced organoid branching in a significantly higher proportion of organoids than FGF2 or FGF9, irrespective of EGF presence ([Supplementary Figures 4B,C](#SM1){ref-type="supplementary-material"}). The absence of EGF significantly reduced branching of organoids formed with FGF9 ([Supplementary Figure 4B](#SM1){ref-type="supplementary-material"}). The most complex organoids with the highest number of branches were then produced by treatment with FGF7 or FGF10 ([Supplementary Figures 4B,C](#SM1){ref-type="supplementary-material"}).

We then investigated whether preculturing of lung epithelial cells with FGF2, followed by cultivation with different FGFs, would affect organoid formation and branching. We first cultured the lung epithelial cells for 7 days with 1 nM FGF2 only and then continued with the culture in media containing 1 nM FGF2, or FGF7, or FGF9, or FGF10 ([Figure 2I](#F2){ref-type="fig"}). Overall, the preculture with FGF2 had a positive effect on organoid formation. It rescued the inability of FGF9 to efficiently support organoid formation and also significantly increased organoid formation in a medium with FGF7, FGF9, and FGF10, respectively ([Figures 2I,J](#F2){ref-type="fig"}). In contrast to its effect on organoid formation, 7-day preculture with FGF2 did not influence organoid branching ([Figure 2K](#F2){ref-type="fig"}). Still, the organoids cultured in FGF7 and FGF10, respectively, were superior in their branching capability compared to those cultured continuously in only FGF2 ([Figure 2K](#F2){ref-type="fig"}). This observation suggests that in the initial phase of lung organoid formation, cell survival and/or proliferation, which is efficiently supported by FGF2, might be the deciding factors for further organoid development. Then, in the later stage of lung organoid growth and patterning, organoid morphogenesis may be more driven by signals from FGF7, FGF9, and FGF10.

Collectively, our data indicate that at least *ex vivo*, FGF ligands assayed here may have partially redundant functions. An intriguing role seems to be played by FGF9 that has minimal capacity to promote organoid formation from single cells but is a strong organoid-stimulating signal in later stages of their morphogenesis.

Lung Organoids Contain Both of Alveolar-Like and Airway-Like Structures {#S2.SS4}
-----------------------------------------------------------------------

Next, we characterized the overall histological structure and cell type composition of lung organoids using hematoxylin-eosin staining and immunohistochemistry. Because FGF10 plays an important role during lung specification and morphogenesis ([@B39]; [@B46]), and because it acted as one of the most effective inducers of lung organoid formation and branching in our experiments, we focused our attention primarily to the organoids formed with FGF10. Typically, we detected the presence of basally localized K5-positive cells and luminally localized K8-positive cells, in both more cystic-like and branched organoids ([Figures 3A,B](#F3){ref-type="fig"}). The organoids contained airway-like regions with ciliated cells (positive for acetylated tubulin) ([Figure 3C](#F3){ref-type="fig"}) and club cells (positive for CC10), as well as alveolar-like regions with cells expressing ATII and ATI cell markers pro-SPC and AQP5, respectively ([Figure 4](#F4){ref-type="fig"}). Distal lung patterning (indicated by positivity for NKX2-1) was more prominent in the organoids than the proximal patterning (SOX2) ([Figure 4](#F4){ref-type="fig"} and [Supplementary Figure 5](#SM1){ref-type="supplementary-material"}). Organoids formed in the presence of FGF2, FGF7, or FGF9 showed cellular composition similar to the organoids formed with FGF10 according to histological and immunofluorescence analysis ([Figure 4](#F4){ref-type="fig"}). However, qPCR analysis revealed several interesting differences in the expression of lung epithelial cell genes in organoids treated with different FGF ligands. Overall, organoids formed with FGF7 showed very similar gene expression profile to organoids formed with FGF10. They both showed downregulated expression of proximal lung marker *Sox2*, and increased expression of distal lung markers *Sox9* and *Nkx2-1*, ATI marker *Aqp5, Calca* (neuro-endocrine cell marker), *Foxi* (pulmonary ionocyte marker), *Muc5ac* and *Muc5b*, surfactant genes *Sftpa1, Sftpb*, and *Sftpc*, and club cell marker *Scgb1a1.* Organoids formed with FGF9 demonstrated markedly decreased expression of surfactant genes and *Calca*, but increased expression of *Foxj* (marker of ciliated cells) and *Krt5* ([Figure 5](#F5){ref-type="fig"}).

![Lung organoids recapitulate cellular composition and organization of the lung. **(A,B)** Lung organoids have complex organization with basally localized keratin 5 positive cells and luminally localized keratin 8 positive cells. The photographs show paraffin sections of an organoid cultured in 3D Matrigel with FGF10, stained with hematoxylin/eosin (H&E) or by immunohistochemistry for keratin 5 (K5) or 8 (K8). Scale bar, 100 μm. **(B)** A whole-mount 3D confocal image of an organoid cultured in 3D Matrigel with FGF10, stained by immunofluorescence for keratin 5 (K5) and 8 (K8). Scale bar, 100 μm. **(C)** Immunofluorescence analysis of paraffin sections of lung organoids for acetylated tubulin (AcTub), a marker of ciliated cells. Blue, nuclei (DAPI). Scale bar, 100 μm.](fcell-08-00574-g003){#F3}

![Lung organoids formed with different FGF ligands show similar cellular composition, including both alveolar-like regions and airway-like regions. The photographs show immunofluorescence analysis of paraffin sections of lung organoids for markers of ATII cells (Pro-SPC), club cells (CC10), ATI cells (AQP5), distal lung lineages (NKX2-1), and proximal lung lineages (SOX2). Blue, nuclei (DAPI). Scale bar, 100 μm.](fcell-08-00574-g004){#F4}

![FGF ligands demonstrate differences in promoting certain lung epithelial cell types. Results from qPCR analysis of expression of candidate genes in organoids grown with different FGF ligands (1 nM). The plots show mean + SD, *n* = 3 (2 for *Sox2, Sox9*, and *Nkx2-1*). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001 (one-way ANOVA).](fcell-08-00574-g005){#F5}

These results indicate that the lung organoid system, elaborated and used here, achieves cell differentiation to a wide range of lung epithelial cell lineages and that FGF ligands influence differentiation to certain lung epithelial cell types differently.

WNT3A Increases the Efficiency of Lung Organoid Formation and FGF10 Promotes Differentiation to Lung Epithelial Cell Lineages {#S2.SS5}
-----------------------------------------------------------------------------------------------------------------------------

WNT signaling plays an essential role during lung development ([@B14]) and repair after injury ([@B53]; [@B25]). Moreover, WNT signaling is critically important for self-renewal and specification of stem cells in multiple organs ([@B7]) and has been successfully employed in protocols for the production of organoids from several organs, including lungs ([@B25]). Therefore, here we also investigated the formation of lung organoids under the conditions involving WNT signals.

The WNT-based protocols typically combine WNT3A, R-Spondin1 (WNT agonist), Noggin (bone morphogenic protein inhibitor), and EGF and, optionally, also FGFs, to support organoid growth in basement membrane ECM. WNT3A can be supplemented to the medium in the form of recombinant protein from a commercial supplier, or in the form of a WNT3A-conditioned medium (WCM; [@B44]). We tested both approaches.

WNT3A efficiently promoted lung organoid formation, but WCM was significantly less effective in this phenomenon ([Figures 6A,B](#F6){ref-type="fig"}). Moreover, in the culture variant with WCM, we observed a striking new phenotype -- colonies of cells of mesenchymal-like morphology ([Figures 6A,C](#F6){ref-type="fig"}). These colonies started off as epithelial structures but changed into mesenchymal-like cells, intriguingly resembling the process of epithelial-to-mesenchymal transition (EMT). We hypothesized that factor(s) responsible for such effect of WCM may originate from the serum contained in WCM preparation as part of the culture medium. Therefore, we prepared also serum-free WCM (WCM-I) by culturing cells in a medium containing ITS (insulin--transferrin--selenium) instead of serum. As expected, the EMT-like phenotype was much less pronounced in the WCM-I compared to serum-containing WCM (WCM-S). Also, WCM-I was superior to WCM-S in the efficiency of organoid production ([Figures 6A--C](#F6){ref-type="fig"}).

![WNT3A enhances the efficiency of lung organoid formation and addition of FGF10 promotes organoid differentiation. **(A)** Representative photographs of lung organoids formed with WNT-based protocol in 3D Matrigel. WCM-S, WNT3A-conditioned medium with serum; WCM-I, serum-free WNT3A-conditioned medium (with ITS); EMT, epithelial to mesenchymal transition. **(B,C)** Primary lung organoid forming efficiency (OFE; **B**) and efficiency of formation of EMT colonies **(C)**. The plots show mean + SD; *n* = 3. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001 (one-way ANOVA). **(D,E)** FGF10 increases lung organoid formation efficiency and decreases EMT occurrence in the cultures with WCM-based media. The plots show mean + SD; *n* = 3. \*\*\**P* \< 0.001; \*\*\**P* \< 0.001 (two-way ANOVA). **(F)** Brightfield images (BF), histological analysis (H&E), and immunofluorescence staining of lung organoids. Scale bar, 100 μm. The area marked by white dashed line is magnified in the picture on the right; scale bars represent 50 μm in the magnified picture. The arrows indicate nuclear localization of β-catenin. **(G)** The plots show proportion of K5 positive (+) or K8 + cells in the total number of keratin + (sum of K5 + and K8 + cells) cells, and CC10 + and Pro-SPC + cells in the total number of cells in the organoid sections as mean + SD; *n* = 4, *N* = 3 organoids per experiment. \**P* \< 0.05; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001 (one-way ANOVA). **(H)** Results from qPCR analysis of expression of candidate genes of WNT3A treatment with or without FGF10. *Actb* and *Eef1g* were used as reference genes for normalization. The plots show mean + SD, *n* = 3. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001 (Student's *t*-test).](fcell-08-00574-g006){#F6}

Because of the important role of FGF10 during lung epithelial development, also demonstrated here, we further investigated the effect of FGF10 on the formation of lung organoids under conditions utilizing WNT signaling. Curiously, while FGF10 did not potentiate organoid forming efficiency when combined with WNT3A, it did significantly increase organoid formation in cultures containing either type of WCM ([Figure 6D](#F6){ref-type="fig"}). FGF10 also significantly reduced the occurrence of EMT-like phenotype in WCM-containing cultures ([Figure 6E](#F6){ref-type="fig"}).

Histological and immunohistochemical analysis of lung organoids produced under conditions containing WNT3A alone or WNT3A plus FGF10, respectively, demonstrated that the presence of FGF10 dramatically increased a degree of organoid differentiation. Specifically, organoids grown under the influence of FGF10 contained expanded lung-like regions ([Figure 6F](#F6){ref-type="fig"}) and typically expressed much higher numbers of K8-, Pro- SPC-, and CC10-positive cells ([Figures 6F,G](#F6){ref-type="fig"}). The organoids formed with WNT3A only were more compact and contained several layers of less differentiated basal cells ([Figure 6F](#F6){ref-type="fig"}). It is of note that organoids produced under conditions containing WNT3A showed nuclear localization of β-catenin, thus documenting activation of the WNT signaling pathway ([Figure 6F](#F6){ref-type="fig"}).

We have further approached the regulatory significance of WNT and FGF10 by quantifying the expression of 16 genes that define specific types of cells and/or stages of development of lung epithelial cell lineages ([Figure 6H](#F6){ref-type="fig"}). To this end, the organoids were cultured in the media containing WNT3A with or without FGF10. The key findings were as follows. The organoids expressed all the genes assayed, however, the expression levels were influenced by the presence and absence of FGF10. Although the statistical significance of the differences varied among the individual genes, overall, the expression of genes associated with differentiated cell phenotypes was higher in organoids formed in an FGF10-containing medium. Specifically, this difference was very highly pronounced for genes encoding AQP5 (*Aqp5*; ATI cells), CFTR (*Cftr*; anion secretory cells), EpCAM (*Epcam*; epithelial cells), forkhead box protein J1 (*Foxj1*; ciliated cells), CC10 (*Scgb1a1*; club cells), SP-A (*Sftpa1*; ATII cells), SP-B (*Sftpb*; ATII cells), and SP-C *(Sftpc*; ATII cells); less pronounced for CGRP (*Calca*; neuroendocrine cells), P450 (*Cyp2f2*; club cells), K8 (*Krt8*; epithelial cells), mucin 5B (*Muc5b*; mucosa cells), and podoplanin (*Pdpn*; ATI cells); and statistically insignificant for forkhead box protein I1 (*Foxi1;* pulmonary ionocytes) and mucin 5A/C (*Muc5ac*; mucosa cells). Importantly, FGF10 decreased the expression of stemness-associated K5 gene (*Krt5;* basal cells). Comparison of the gene expression in the presence of WNT3A, WNT3A + FGF10, or FGF10 only revealed that these genes were indeed regulated by FGF10 ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}). FGF10 did not influence intracellular action of WNT3A, as indicated by sustained expression of WNT target *Axin2* ([Figure 6H](#F6){ref-type="fig"} and [Supplementary Figure 6](#SM1){ref-type="supplementary-material"}). Together, this set of data identifies WNT3A as a factor that preferentially enhances organoid formation, whereas FGF10 drives differentiation of cells within the organoids.

Discussion {#S3}
==========

FGF and WNT signaling pathways are essential components of the gene regulatory network in the lungs. They coordinate maintenance of stem/progenitor cells, epithelial/mesenchymal patterning, and branching morphogenesis during lung development and repair ([@B47]). In this study, we investigated the roles of FGF ligands and also WNT3A in lung epithelial morphogenesis using 3D cell culture models that we have developed. Our main findings are summarized in [Figure 7](#F7){ref-type="fig"}.

![Schematic presentation of the role of FGF and WNT signaling in lung organoid formation and differentiation. FGF ligands differ in their capacity to promote lung organoid formation and branching, and in directing cell differentiation toward proximal or distal lung lineages. FGF9 has the lowest capacity for lung organoid formation and branching, and higher capacity for directing cells toward proximal lung lineages. FGF7 and FGF10 have the highest capacity to promote lung organoid formation, branching, and differentiation toward distal lung lineages. WNT signaling is a very potent inducer of lung organoid formation and growth, but FGF signaling is required for efficient differentiation to lung lineages. LSPC, lung stem/progenitor cell.](fcell-08-00574-g007){#F7}

Our study revealed that unsorted lung epithelial cells as well as sorted LSPCs (EpCAM^+^ CD49f^+^ CD24^low^ CD104^+^) are capable of proliferation, self-renewal, and differentiation in non-adherent conditions to form spheres, similar to epithelial stem cells from other organs ([@B40]; [@B42]; [@B56]). The lungospheres formed structures that could be categorized into three phenotypes, which were similar to the phenotypes described for LSPC-derived organoids grown in ECM ([@B30]), suggesting that the mechanisms underlying these phenotypes are independent of the ECM. However, embedding of the lungospheres in 3D ECM (Matrigel) supported further development, including growth and morphological changes of the lungospheres into lung organoids with branched lung-like structures.

Direct seeding of unsorted lung epithelial cells into Matrigel promoted organoid formation at similar efficiency as culture in non-adherent conditions, suggesting that the lungospheres and lung organoids come from the same type of cells. Importantly, while several studies reported that co-culture with stromal cells is required for distal LSPCs to form lung-like epithelial structures ([@B30]; [@B6]; [@B2]; [@B24]; [@B19]), our cell culture method in the defined medium with EGF and FGF ligands enables lung organoid formation without the need for stromal cells. Several studies reported the ability of FGF ligands to replace the requirement for stromal support ([@B30]; [@B19]). Interestingly, in these studies, 5--10 times higher concentration of FGF was used than in our study, suggesting that our cell culture protocol is more effective. Our study also shows the advantage of using hyperstable growth factor variants, such as FGF2-STAB, for lung organoid culture, and extends the cell culture potential of FGF2-STAB beyond the reported use in human embryonic stem cell culture ([@B13]).

Our experiments addressing organoid forming efficiency and organoid morphology revealed that FGF ligands FGF2, FGF7, FGF9, and FGF10 act only partially redundantly *ex vivo*. All tested FGF ligands were capable of supporting organoid formation and branching, with FGF9 showing a significantly lower capacity to promote lung organoid formation compared to other FGF ligands ([Figure 7](#F7){ref-type="fig"}). However, preculture with FGF2 followed by further culture with FGF9 was able to rescue the low organoid formation, typical for treatment with only FGF. Moreover, preculture with FGF2 further increased the organoid forming efficiency of FGF7, FGF9, and FGF10, suggesting that FGF2 supported cell survival and/or proliferation more efficiently than other FGF ligands. In contrast to our *ex vivo* observations, only FGF10 is essential for lung development *in vivo*. FGF10 null mice show complete lung agenesis ([@B32]; [@B41]), whereas inactivation of FGF2, FGF7, or FGF9 affects only lung patterning and branching morphogenesis ([@B17]; [@B57]; [@B52]). In concordance with different roles for FGF ligands in lung patterning *in vivo*, we found that FGF ligands differ in their capacity to direct cell differentiation *ex vivo* toward proximal or distal lung lineages ([Figure 7](#F7){ref-type="fig"}).

WNT signaling plays important roles in self-renewal and differentiation of stem cell in adults as well as during embryonic development ([@B33]; [@B7]; [@B3]). WNT3A was reported to potentiate alveolar organoid formation from ATII cells and also expansion of ATII cells *ex vivo* ([@B14]; [@B25]). Furthermore, WNT activation promotes clonal expansion of ATII cells during alveologenesis *in vivo* ([@B14]). In this study, we showed that WNT3A significantly increases organoid forming efficiency of unsorted lung epithelial cells in comparison to WNT3A-free conditions ([Figure 7](#F7){ref-type="fig"}). Importantly, we report on major differences in organoid forming efficiency depending on the source of WNT3A. Recombinant WNT3A demonstrated the highest capacity to promote organoid formation, while conditioned media from cells expressing WNT3A showed lower capacity to promote organoid formation. While the lower capacity to support organoid formation could, in theory, be compensated by increasing the proportion of the WNT3A-conditioned medium in the organoid medium, it would not bring much advantage. That is because the WNT3A-conditioned medium also induces formation of disorganized colonies of mesenchymal-like cells. These colonies arise probably through epithelial-to-mesenchymal transition (EMT) of lung epithelial cells because we frequently observed transition of smooth, epithelial-like organoid structures to mesenchymal-like colonies of spiky morphology. The L-cell-derived factors that induce such EMT-like behavior remain to be determined.

When FGF10 was added to the WCM-based medium, it increased the efficiency of organoid formation and decreased the incidence of mesenchymal-like structures. However, when FGF10 was added to the medium with recombinant WNT3A, it did not increase the formation of organoids any further, suggesting that WNT3A saturated organoid formation to its maximum. Still, we observed significantly higher expression of markers of all lung cell lineages, suggesting that FGF10 promoted organoid differentiation to both airway and distal lung epithelium. This is consistent with the reported role of FGF10 in the regulation of lung progenitor differentiation based on the developmental context ([@B46]) as well as during homeostasis and in regeneration ([@B48]; [@B55]).

3D culture models of the lung, including lung organoids, represent an invaluable tool for developmental biology, cancer biology, pharmacology, and disease modeling ([@B1]; [@B38]). They offer a wide range of modalities and can be adjusted according to research needs. In this work, we developed and utilized a lung organoid model based on unsorted lung epithelial cells cultured in Matrigel in a defined medium to assess the role of FGF and WNT signaling in lung epithelial morphogenesis. Our findings contribute to better understanding of the complex signaling pathways involved in lung organogenesis with potential applications in tissue engineering and regenerative medicine. Furthermore, as demonstrated, our model can be used for testing of growth factor variants created by protein engineering and potentially other proteins or bioactive substances, providing that the targeted pathways are involved in lung epithelial morphogenesis, including cell survival, proliferation, or differentiation.

Materials and Methods {#S4}
=====================

Mice {#S4.SS1}
----

Female ICR mice of 6--10 weeks of age were used as donors of the lung tissue. The mice were housed, handled, and sacrificed in accordance with the Czech and European laws for the use of animals in research, under a valid project license at the Laboratory Animal Breeding and Experimental Facility of Masaryk University.

Isolation of Lung Epithelial Cells by Differential Centrifugation {#S4.SS2}
-----------------------------------------------------------------

Lung epithelial cells were isolated as described previously ([@B38]). Briefly, the lungs were mechanically disintegrated using scalpels and digested by a solution of collagenase and trypsin \[2 mg/ml collagenase A, 2 mg/ml trypsin, 5 μg/ml insulin, 50 μg/ml gentamicin (all Sigma/Merck), 5% fetal bovine serum (FBS; Hyclone/GE Healthcare) in DMEM/F12 (Thermo Fisher Scientific)\] for 45 min at 37°C with shaking. The resulting tissue suspension was centrifuged, and the pellet was treated with a red blood cell lysis buffer \[155 mM NH~4~Cl (Penta), 12 mM NaHCO~3~ (Fluka), 0.1 mM EDTA (Merck) in distilled H~2~O, pH 7.4, filter sterilized\]. After washing with DMEM/F12 and centrifugation, the cell pellet was treated by DNase I (20 U/ml; Merck). After a final wash with DMEM/F12, the cell pellet was exposed to five rounds of differential centrifugation to remove mesenchymal cells. The resulting pellet of primary lung epithelial organoids was further processed by incubation in HyQTase (Hyclone/GE Healthcare) and repetitive pipetting to produce single-celled suspension.

Isolation of Lung Epithelial Stem/Progenitor Cells by FACS {#S4.SS3}
----------------------------------------------------------

LSPCs were isolated as described previously ([@B29]; [@B38]). Briefly, the lungs were chopped up using scalpels, and the resulting mince was digested by Liberase (0.048 mg/ml; Roche) and incubated for 45 min at 37°C with shaking. The suspension was passed through 18G and 21G needles and treated with DNase I (20 U/ml). Next, the suspension was passed through a 100 μm cell strainer, treated with a red blood cell lysis buffer, and passed through a 40 μm cell strainer. The resulting single-celled suspension was centrifuged to collect the cells. The pellet was suspended in a blocking buffer \[1% BSA in HBSS (both Merck)\] and incubated for 20 min at room temperature. After centrifugation, the cells were resuspended at 1 × 10^7^ cells/ml in a FACS buffer containing the selection antibody cocktail (anti-CD104, anti-EpCAM, anti-CD24, anti-CD49f, anti-CD45; see [Supplementary Table 1](#SM1){ref-type="supplementary-material"}) and incubated in ice in the dark for 20 min. The cells were washed with HBSS, passed through a 30 μm cell strainer, and incubated with 10 μl/ml 7-ADD (BD Biosciences) for 5 min in ice in the dark. Cells were then sorted using FACSAria II SORP (BD Biosciences).

Lungosphere Culture in Non-adherent Conditions {#S4.SS4}
----------------------------------------------

Lung epithelial cells were cultured in non-adherent conditions as described previously ([@B38]). Briefly, for primary lungosphere assay, unsorted lung epithelial cells were seeded in polyHEMA-treated six-well plates at 2.5 × 10^4^ to 5 × 10^4^ cells in 2 ml/well of a lungosphere medium \[1 × B-27 without vitamin A, 100 U/ml penicillin, 100 μg/ml streptomycin (all Thermo Fisher Scientific), 4 μg/ml heparin (Sigma/Merck), 20 ng/ml murine EGF (\#315-09, Peprotech), 10 ng/ml FGF2-STAB (thermostable FGF2 based on human FGF2 sequence; Enantis), or 10 ng/ml human FGF2-wt (\#100-18C, Peprotech), 10 μM Y-27632 (Merck) in phenol red-free DMEM/F12 (Thermo Fisher Scientific)\]; or 500--1000 FACS-sorted cells were seeded in polyHEMA-treated 24-well plates in 1 ml/well of a lungosphere medium. The plates were incubated in a humidified atmosphere at 37°C, 5% CO~2~. A fresh lungosphere medium (without Y-27632) was added every 3 days. Lungospheres were counted after 10--15 days of culture. To passage lungospheres (for secondary and tertiary lungosphere assay), the lungospheres were collected from the plates and processed to single-celled suspension by HyQTase digestion and repetitive pipetting. Resulting single cells were reseeded in polyHEMA-treated plates in a lungosphere medium at the same density as for primary assay. Lungosphere forming efficiency (LFE,%) was calculated as (number of lungospheres formed)/(number of cells seeded) × 100.

Embedded Culture of Lungospheres in 3D Matrigel {#S4.SS5}
-----------------------------------------------

The lungospheres were collected from the polyHEMA-treated plates, washed with DMEM/F12 and then with a basal culture medium \[1 × ITS (10 μg/ml insulin, 5.5 μg/ml transferrin, 6.7 ng/ml selenium), 100 U/ml penicillin, 100 μg/ml streptomycin in DMEM/F12 (all Thermo Fisher Scientific)\]. Then the lungospheres were mixed with Matrigel (growth factor reduced; Corning) and plated into a Matrigel-coated 24-well plate in domes. The plate was incubated at 37°C for 30--45 min before adding a basal culture medium supplemented with growth factors as needed. The plate was incubated in a humidified atmosphere of a cell culture incubator (37°C, 5% CO~2~). The medium was changed every 2--3 days.

Lung Organoid Culture in 3D Matrigel {#S4.SS6}
------------------------------------

The unsorted or sorted lung epithelial cells were resuspended in Matrigel and plated into a Matrigel-coated 24-well plate in domes (1--2 × 10^4^ cells in 50 μl Matrigel/well). The plate was incubated at 37°C for 30--45 min before adding 1 ml of medium per well. The cells were incubated in a humidified atmosphere of a cell culture incubator (37°C, 5% CO~2~). The medium was changed every 3 days. The media used were the following: Lungosphere medium \[1 × B-27 without vitamin A, 100 U/ml penicillin, 100 μg/ml streptomycin, in phenol red-free DMEM/F12\], supplemented with EGF (20 ng/ml) and/or FGFs \[1 or 2 nM FGF2-STAB, FGF2-wt, murine FGF7 (\#450-60, Peprotech), murine FGF9 (\#450-30, Peprotech), or human FGF10 (\#100-26, Peprotech)\] as needed according to experiment, and 10 μM Y-27632 (only for the first 3 days of culture); a WNT lung organoid medium ([@B25]): 50 ng/ml murine WNT3A (\#315-20, Peprotech) or 50% WNT3A-conditioned medium,100 ng/ml murine Noggin (\#250-38, Peprotech), 500 ng/ml human R-spondin 1 (\#120-44, Peprotech), and 40 ng/ml EGF in lungosphere medium, with or without 40 ng/ml FGF10. Organoid forming efficiency (OFE,%) was calculated as (number of organoids formed)/(number of cells seeded) × 100. Organoid size was measured from organoid photographs using ImageJ (NIH) as the area occupied by the organoid.

Production of WNT3A-Conditioned Medium {#S4.SS7}
--------------------------------------

A WNT3A-conditioned medium (WCM) was prepared using the cell line L WNT3A (ATCC^®^, CRL-2647^TM^) ([@B44]). The L cells were cultured in a DMEM (Thermo Fisher Scientific), 100 U/ml penicillin, and 100 μg/ml streptomycin with 10% FBS or 1× ITS. The medium was collected and sterile filtered after 3 days of culture (first batch), then a fresh medium was added to the cells for another 2 days until the medium was collected and sterile filtered (second batch). The first and second batches of the medium were mixed (1:1), resulting in the WCM. The WCM was aliquoted and stored at −20°C until use.

Histological and Immunohistochemical Analysis {#S4.SS8}
---------------------------------------------

The lungospheres formed in non-adherent conditions or organoids formed in 3D Matrigel were fixed with 4% paraformaldehyde in PBS for 30 min, washed with PBS, and embedded in 3% low melting point agarose (Merck). Then the samples were processed via standard procedure for paraffin embedding. Paraffin sections were cut (2 μm thickness), deparaffinized using xylene, and rehydrated. For histological analysis, the sections were stained with hematoxylin and eosin, dehydrated, and mounted in Pertex (Histolab Products). For immunohistochemistry analysis, antigens were retrieved using a Citrate buffer (Dako) for 30 min, and endogenous peroxidase activity was blocked using 3% hydrogen peroxide. The sections were blocked in PBS with 10% FBS and incubated with primary antibody ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}) for 1 h at RT. After washing, sections were incubated with secondary antibody (anti-mouse, EnVision + Dual Link System-HRP; Dako) for 30 min at RT. After washing, bound secondary antibody was detected using Liquid DAB + Substrate Chromogen System (Dako). The nuclei were stained with Mayer's hematoxylin, dehydrated, and mounted in Pertex. The photographs were taken using a Leica DM5000B microscope equipped with a Leica DFC480 camera. For immunofluorescence analysis, the sections were immersed in a citrate buffer and blocked with PBS with 10% FBS. Then the sections were incubated with primary antibodies ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}) overnight at 4°C. After washing, the sections were incubated with secondary antibodies ([Supplementary Table 1](#SM1){ref-type="supplementary-material"}) for 2 h at RT. Then the sections were washed, stained with DAPI (1 μg/ml; Merck) for 10 min, and mounted in Mowiol (Merck). Fluorescence was detected and documented using a Nikon Eclipse Ti2 inverted microscope or using an Olympus FV500 and FV3000 confocal laser scanning microscope.

Real-Time Quantitative PCR (qPCR) {#S4.SS9}
---------------------------------

RNA was isolated using an RNeasy Mini Kit (Qiagen) according to the manufacturer's instruction. cDNA was prepared using a High Capacity RNA-to-cDNA kit (Thermo Fisher Scientific). Real-time qPCR was performed using 5 ng cDNA, 5 pmol of the forward and reverse gene-specific primers each (primer sequences shown in [Supplementary Table 2](#SM1){ref-type="supplementary-material"}) in Light Cycler SYBR Green I Master mix (Roche) on LightCycler 480 II (Roche). Relative gene expression was calculated using the ΔΔCt method and normalization to two housekeeping genes, β-actin (*Actb*) and Eukaryotic elongation factor 1 γ (*Eef1g*).

Statistics {#S4.SS10}
----------

Statistical analysis was performed using the Prism software (GraphPad) using Student's *t*-test and ANOVA. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001, and ^\*\*\*\*^*P* \< 0.0001. The number of independent biological replicates is indicated as *n*.
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AQP5

:   aquaporin 5

ATI

:   alveolar type I cell

ATII

:   alveolar type I cell

CC10

:   club cells specific 10 protein

ECM

:   extracellular matrix

EGF

:   epithelial growth factor

EMT

:   epithelial to mesenchymal transition
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:   fluorescence-activated cell sorting

FGF

:   fibroblast growth factor

FGF2-STAB
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FGF2-wt
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FGFR

:   fibroblast growth factor receptor
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:   keratin 5
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:   keratin 8

LFE

:   lungosphere forming efficiency

LSPC

:   lung epithelial stem/progenitor cells

OFE

:   organoid forming efficiency

pro-SPB

:   pro-surfactant protein B
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:   pro-surfactant protein C

WCM

:   WNT3A-conditioned medium.
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